Reserpine

Reserpine
Product Description

Indena SpA offers a wide range of pharmaceutical products which includes reserpine. Botanical origin: rauvolfia vomitoria afz. root bark. Biological activity: antihypertensive. Contact us for more information.

Indena S.P.A

  • IT
  • 2015
    On CPHI since
  • 5
    Certificates
  • 500 - 999
    Employees
Company types
CMO/CDMO
Manufacturer/Innovator
Pharmaceutical company
Primary activities
API Producer
Contract Manufacturer
Custom Manufacturing/Custom Synthesis
Nutraceuticals
Specifications
  • Selling Points
    Assay: ?99.0% ?101.0% by potentiometry

Indena S.P.A

  • IT
  • 2015
    On CPHI since
  • 5
    Certificates
  • 500 - 999
    Employees
Company types
CMO/CDMO
Manufacturer/Innovator
Pharmaceutical company
Primary activities
API Producer
Contract Manufacturer
Custom Manufacturing/Custom Synthesis
Nutraceuticals

More Products from Indena S.P.A (41)

  • Lenvatinib mesylate
  • Lymphaselect®

    Product Lymphaselect®

    Indena SpA offers a wide range of pharmaceutical products which includes lymphaselect®. Botanical origin: melilotus officinalis (l.) pallas herb. Biological activity: lymphatic circulation improver. Contact us for more information.
  • Myrtocyan®

    Product Myrtocyan®

    Indena SpA offers a wide range of pharmaceutical products which includes myrtocyan®. Botanical origin: vaccinium myrtillus l. fresh frozen fruit. Biological activity: ophtalmic, capillarotropic. Contact us for more information.
  • Paclitaxel

    Product Paclitaxel

    Indena SpA offers a wide range of pharmaceutical products which includes paclitaxel. Botanical origin: taxus media rehder root, leaf and twig. Biological activity: anti-mitotic / anticancer. 
  • Paclitaxel S

    Product Paclitaxel S

    Indena SpA offers a wide range of pharmaceutical products which includes paclitaxel s. Botanical origin: taxus baccata (l.) leaf and twig. Biological activity: anti-mitotic / anticancer. 
  • Prunuselect®

    Product Prunuselect®

    Indena SpA offers a wide range of pharmaceutical products which includes prunuselect®. Botanical origin: prunus africana (hook. f.) kalkm. bark. Biological activity: anti-bph. Contact us for more information.
  • Reserpine Micronized

    Product Reserpine Micronized

    Indena SpA offers a wide range of pharmaceutical products which includes reserpine micronized. Botanical origin: rauvolfia vomitoria afz. root bark. Biological activity: antihypertensive. Contact us for more information.
  • Reserpine Usp

    Product Reserpine Usp

    Indena SpA offers a wide range of pharmaceutical products which includes reserpine usp. Botanical origin: rauvolfia vomitoria afz. root bark. Biological activity: antihypertensive. Contact us for more information.
  • Ruscogenins

    Product Ruscogenins

    Indena SpA offers a wide range of pharmaceutical products which includes ruscogenins. Botanical origin: ruscus aculeatus l. rhizome and root. Biological activity: antihaemorrhoidalvenotropic. Contact us for more information.
  • Saw Palmetto Alcoholic Extract

    Product Saw Palmetto Alcoholic Extract

    Indena SpA offers a wide range of pharmaceutical products which includes saw palmetto alcoholic extract. Botanical origin: serenoa repens (bartr.) small fruit. Biological activity: antiandrogen, anti-bph. Contact us for more information.
  • Saw Palmetto Extract

    Product Saw Palmetto Extract

    Indena SpA offers a wide range of pharmaceutical products which includes saw palmetto extract. Botanical origin: serenoa repens (bartr.) small fruit. Biological activity: antiandrogen, anti-bph. Contact us for more information.
  • Sennosides 45%

    Product Sennosides 45%

    Indena SpA offers a wide range of pharmaceutical products which includes sennosides 45%. Botanical origin: cassia angustifolia vahl. leaf. Biological activity: laxative. Contact us for more information.

Indena S.P.A resources (3)

  • Video From the Rainforest to the Clinic. Turning a High-Potency Rare Natural Product Into an Anticancer API

    Natural products can be characterized by complex structure, limited availability, and exceptional potency, whose combination makes it challenging their development as API. Success requires integration of expertise in different areas, including the construction of a sustainable supply chain for the starting biomass, the capacity to manipulate high-potency products in a GMP environment, and the versatility to strategically complement isolation with semi-synthesis, total synthesis and biotechnology. In this context, mutual thrust between the service provider company and the drug candidate owner is critical, and the successful development of the anticancer drug tigilanol tiglate will give the opportunity to address these issues.
  • Whitepaper CDMO services

    We have a unique expertise in developing and manufacturing HPAPIs. The company is equipped with kilolabs (for clinical and small commercial batches) and large industrial suite for HPAPIs with an OEL>20 ng/m3.